Savulescu Warns that “Love-Diminishing” Drugs could be Used for Gay “Conversion Therapy”
By Xavier Symons,
BioEdge
| 10. 12. 2013
In recent years Oxford bioethicist Julian Savulescu has written extensively about the neuro-enhancement of human relationships. In a number of papers, he has studied the ethics of using drugs to strengthen or improve romantic relationships. But how about the use of “individual, voluntary use of love-diminishing biotechnology”? In other words, drugs which would inhibit or reduce love or sexual attraction. If love is essentially chemical, the tap can be turned on or off.
Although this is currently not feasible, Savulescu and co-authors Brian D. Earp and Anders Sandberg warn that drugs could be used to reverse homosexual inclinations. In a controversial paper in the
American Journal of Bioethics: Neuroscience, “
Brave new love: The threat of high-tech ‘conversion’ therapy and the bio-oppression of sexual minorities”, they examine the ethics of using drugs to “normalize” people with atypical sexual desires.
They conclude that the use of conversion drugs on minors should be illegal but “in rare cases” they could be used by consenting adults, even if they are religious fundamentalists. “It seems hard to maintain… that John Stuart Mill’s...
Related Articles
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Jennifer Takhar, Carolyn Wilson-Nash, and Chloe He, BioNews | 06.22.2026
Imagine wanting to have a child and discovering, at every stage, that the system was not designed with you in mind. This is the reality for many LGBTQ+ people in the UK who seek fertility treatment each year.
Our study...
By Mark Ellwood, Air Mail | 06.06.2026
How much would you pay to be a parent? For years, Americans who turned to surrogacy could expect to spend about $100,000 on what the industry calls the “surrogacy journey.” For deep-pocketed intended parents—the term for those who plan to...
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...